Form D — Rhinal Therapeutics Inc.
0002080382-25-000001 · filed 2025-08-07
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,000,000
- Total sold
- $20,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rhinal Therapeutics Inc.
- CIK
- 2080382
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- 2023
- Address
- 732 S 6TH ST
LAS VEGAS, NV 89101 - Phone
- 7029816980
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Lawrence Fox · Executive OfficerLas Vegas, NV Find on LinkedIn ↗
-
Frank Puglisi · Executive OfficerLas Vegas, NV Find on LinkedIn ↗
-
Austin Panhans · Executive OfficerLas Vegas, NV Find on LinkedIn ↗
-
Robert Clayborough · Executive OfficerLas Vegas, NV Find on LinkedIn ↗
-
Mike George · DirectorLas Vegas, NV Find on LinkedIn ↗
View original on SEC EDGAR.